<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04157972</url>
  </required_header>
  <id_info>
    <org_study_id>SIMEOX-004</org_study_id>
    <nct_id>NCT04157972</nct_id>
  </id_info>
  <brief_title>Effects of SIMEOX on Static Hyperinflation in Patients With COPD</brief_title>
  <official_title>Short-term Effects of SIMEOX on Static Hyperinflation in Patients With Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will investigate the effects on the SIMEOX technology on static hyperinflation in
      patients with chronic obstructive pulmonary disease (COPD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a crossover study assessing the short-term effects of SIMEOX and PEP device on static
      hyperinflation in patients with COPD.

      Patients will perform lung function tests (to assess the residual volume and functional
      residual capacity) before, after and 30 minutes after a 20-min long session of SIMEOX or PEP
      (depending of randomization).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 5, 2019</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>The visits include sessions (test 1 and 2) with SIMEOX or a positive expiratory pressure device (PEP) (chosen according to the subject's randomization) lasting 20 minutes, each followed by a rest period of 30 minutes.
Lung function tests will be performed before, after and 30 minutes after performing the devices (SIMEOX and PEP).</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in functional residual capacity (FRC) using body plethysmography</measure>
    <time_frame>15 minutes</time_frame>
    <description>FRCpleth before, after and 30 minutes after performing SIMEOX and PEP will be compared.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in functional residual capacity (FRC) using helium dilution</measure>
    <time_frame>5 minutes</time_frame>
    <description>FRChe before, after and 30 minutes after performing SIMEOX and PEP will be compared.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in air trapping</measure>
    <time_frame>20 minutes</time_frame>
    <description>FRCpleth - FRChe before, after and 30 minutes after performing SIMEOX and PEP will be compared.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Pulmonary Disease, Chronic Obstructive</condition>
  <arm_group>
    <arm_group_label>SIMEOX</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will have to perform 20 minutes of SIMEOX. Passive exhalation is required using the SIMEOX, starting from tidal volume and going until achieving residual volume.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PEP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will have to perform 20 minutes of PEP. Active exhalation is required using a PEP device, starting from tidal volume and going until achieving residual volume.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SIMEOX</intervention_name>
    <description>SIMEOX is a device generating a succession of gentle depression at the mouth.</description>
    <arm_group_label>SIMEOX</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PEP</intervention_name>
    <description>A PEP device (Pari-PEP) will be used to provoke a positive expiratory pressure while exhaling, thereby stabilizing the airways during expiration.</description>
    <arm_group_label>PEP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with chronic obstructive pulmonary disease,

          -  Forced expiratory volume in 1s (FEV1) &lt;80% of predicted value,

          -  Stable condition (no pulmonary exacerbation for more than 28 days).

        Exclusion Criteria:

          -  Routine use of one of the two treatments - SIMEOX and/or PEP,

          -  Inability to understand or carry out the instructions,

          -  Severe cardiac comorbidity, neuromuscular disease,

          -  Severe scoliosis,

          -  Patient with a pacemaker.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>William Poncin, PT, PhD</last_name>
    <phone>+3227642316</phone>
    <email>william.poncin@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juliana RFF de Macedo, PT, MSc</last_name>
    <email>juliana.ribeiro@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cliniques universitaires Saint-Luc</name>
      <address>
        <city>Brussels</city>
        <state>Brussels Capital</state>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Poncin</last_name>
      <phone>+320470592032</phone>
      <phone_ext>+320470592032</phone_ext>
      <email>william.poncin@uclouvain.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 6, 2019</study_first_submitted>
  <study_first_submitted_qc>November 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2019</study_first_posted>
  <last_update_submitted>November 8, 2019</last_update_submitted>
  <last_update_submitted_qc>November 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</investigator_affiliation>
    <investigator_full_name>Poncin</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

